| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |